We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Advanced Medical Solutions Group Plc | LSE:AMS | London | Ordinary Share | GB0004536594 | ORD 5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
2.40 | 1.24% | 195.40 | 194.80 | 195.60 | 195.60 | 192.00 | 192.40 | 342,131 | 16:35:23 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Plastics,resins,elastomers | 126.21M | 15.89M | 0.0732 | 26.67 | 424M |
TIDMAMS TIDMAV.
RNS Number : 2644H
Advanced Medical Solutions Grp PLC
27 November 2015
For filings with the FCA include the annex For filings with issuer exclude the annex TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i) ------------------------------------------------------------------------------------------------------------ 1. Identity of the issuer or Advanced Medical Solutions the underlying issuer Group plc of existing shares to which voting rights are attached: (ii) ----------------------------------------------------------------- ----------------------------------------- 2 Reason for the notification (please tick the appropriate box or boxes): ------------------------------------------------------------------------------------------------------------ An acquisition or disposal of voting rights ---------------------------------------------------------------------------------------------------------- An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached ---------------------------------------------------------------------------------------------------------- An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments ---------------------------------------------------------------------------------------------------------- An event changing the breakdown of voting rights ---------------------------------------------------------------------------------------------------------- Other (please NOTIFICATION PROMPTED BY THE REMOVAL specify): OF STOCK LENDING EXEMPTION FOLLOWING IMPLEMENTATION OF THE EU TRANSPARENCY DIRECTIVE AMENDMENTS ----------------------------------------------------------- --------------------------------------------- 3. Full name of person(s) Aviva plc & its subsidiaries subject to the notification obligation: (iii) ------------------------------------------------------------- --------------------------------------------- 4. Full name of shareholder(s) Registered Holder: (if different from 3.):(iv) BNY Norwich Union Nominees Limited 447,817* Chase (GA Group) Nominees Limited 5,954,409* Available on Request 43,500* * denotes direct interest ------------------------------------------------------------- --------------------------------------------- 5. Date of the transaction 25 November 2015 and date on which the threshold is crossed or reached: (v) ------------------------------------------------------------- --------------------------------------------- 6. Date on which issuer 27 November 2015 notified: ------------------------------------------------------------- --------------------------------------------- 7. Threshold(s) that is/are 4% to 3% Change at Direct crossed or Interest Level reached: (vi, vii) ------------------------------------------------------------- --------------------------------------------- 8. Notified details: -------------------------------------------------------------------------------------------------------------- A: Voting rights attached to shares (viii, ix) -------------------------------------------------------------------------------------------------------------- Class/type Situation previous Resulting situation after the of to the triggering triggering transaction shares transaction if possible using the ISIN CODE --------------- --------------------------- ---------------------------------------------------------------- Number Number Number Number of voting % of voting of of of shares rights rights (x) Shares Voting Rights --------------- -------------- ----------- ----------- -------------------------- ----------------------- Direct Direct Indirect Direct Indirect (xi) (xii) --------------- -------------- ----------- ----------- ---------- -------------- ------- -------------- Ordinary Shares Not Not GB0004536594 10,358,269 10,358,269 6,445,726 6,445,726 Disclosable 3.09% Disclosable -------------- ----------- ----------- ---------- -------------- ------- -------------- B: Qualifying Financial Instruments -------------------------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction -------------------------------------------------------------------------------------------------------------- Type of Expiration Exercise/ Number of voting % of voting financial date Conversion rights that rights instrument (xiii) Period (xiv) may be acquired if the instrument is exercised/ converted. --------------- -------------- ------------------------ -------------------------- ----------------------- C: Financial Instruments with similar economic effect to Qualifying Financial Instruments (xv, xvi) ---------------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction ---------------------------------------------------------------------------------------------------- Type of financial Exercise Expiration Exercise/ Number of voting % of voting instrument price date Conversion rights instrument rights (xix, (xvii) period refers to xx) (xviii) ------------------- ---------- ------------ ------------- -------------------- ---------------- RIGHT TO N/A N/A N/A 1,829,118 Nominal Delta RECALL LOANED SHARES ------------------- ---------- ------------ ------------- -------------------- -------- ------ 0.88% ------------------------------------------------------------------------------ -------- ------ Total (A+B+C) ------------------------------------------------------ Number of voting rights Percentage of voting rights ------------------------ ---------------------------- 8,274,844 3.97% ------------------------ ---------------------------- 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: (xxi) --------------------------------------------------------------- The voting rights are managed and controlled by Aviva Investors Global Services Limited and Friends Provident International Limited, with the following chain of controlled undertakings:- Aviva Investors Global Services Limited: * Aviva plc (Parent Company) * Aviva Group Holdings Limited (wholly owned subsidiary of Aviva plc) * Aviva Investors Holdings Limited (wholly owned subsidiary of Aviva Group Holdings Limited) * Aviva Investors Global Services Limited (wholly owned subsidiary of Aviva Investors Holdings Limited) Friends Provident International Limited: * Aviva plc (Parent Company) * Aviva Group Holdings Limited (wholly owned subsidiary of Aviva plc) * Aviva Life Holdings UK Limited (wholly owned subsidiary of Aviva Group Holdings Limited) * Friends Life FPG Limited (wholly owned subsidiary of Aviva Life Holdings UK Limited) * Friends Life FPL Limited (wholly owned subsidiary of Friends Life FPG Limited) * Friends Life Limited (wholly owned subsidiary of Friends Life FPL Limited) * Friends Life and Pensions Limited (wholly owned subsidiary of Friends Life Limited) * Friends Provident International Limited (wholly owned subsidiary of Friends Life and Pensions Limited) --------------------------------------------------------------- Proxy Voting: -------------------------------------------------------------------------
(MORE TO FOLLOW) Dow Jones Newswires
November 27, 2015 11:41 ET (16:41 GMT)
1 Year Advanced Medical Solutions Chart |
1 Month Advanced Medical Solutions Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions